Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
WALD Stock Forecast 2025-2026
$2.33
Current Price
$296.54M
Market Cap
Buy 3
Hold 3
Sell 0
Wall St Analyst Ratings
Distance to WALD Price Targets
+71.7%
To High Target of $4.00
+50.2%
To Median Target of $3.50
-14.2%
To Low Target of $2.00
WALD Price Momentum
-7.5%
1 Week Change
+28.0%
1 Month Change
-26.0%
1 Year Change
-42.0%
Year-to-Date Change
-44.3%
From 52W High of $4.18
+57.4%
From 52W Low of $1.48
📊 TOP ANALYST CALLS
Did WALD Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Waldencast is one of their latest high-conviction picks.
Latest WALD Stock Price Targets & Analyst Predictions
Based on our analysis of 8 Wall Street analysts, WALD has a neutral consensus with a median price target of $3.50 (ranging from $2.00 to $4.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $2.33, the median forecast implies a 50.2% upside. This outlook is supported by 3 Buy, 3 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Susan Anderson at Canaccord Genuity, projecting a 71.7% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
WALD Analyst Ratings
3
Buy
3
Hold
0
Sell
WALD Price Target Range
Low
$2.00
Average
$3.50
High
$4.00
Current: $2.33
Latest WALD Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for WALD.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 25, 2025 | Canaccord Genuity | Susan Anderson | Buy | Maintains | $4.00 |
| Nov 25, 2025 | Telsey Advisory Group | Dana Telsey | Market Perform | Downgrade | $3.00 |
| Aug 20, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $3.00 |
| Aug 13, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $4.00 |
| May 15, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $4.00 |
| May 15, 2025 | Canaccord Genuity | Susan Anderson | Buy | Maintains | $5.00 |
| May 6, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $5.00 |
| Apr 22, 2025 | Alliance Global Partners | Aaron Grey | Buy | Initiates | $5.00 |
| Mar 20, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $5.00 |
| Mar 19, 2025 | DA Davidson | Linda Bolton Weiser | Buy | Maintains | $7.50 |
| Mar 19, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $6.00 |
| Mar 11, 2025 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $6.00 |
| Dec 16, 2024 | TD Cowen | Jonna Kim | Hold | Initiates | $4.30 |
| Dec 4, 2024 | DA Davidson | Linda Bolton Weiser | Buy | Maintains | $7.50 |
| Nov 22, 2024 | Canaccord Genuity | Susan Anderson | Buy | Maintains | $6.00 |
| Nov 22, 2024 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $6.00 |
| Nov 18, 2024 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $6.00 |
| Oct 25, 2024 | Canaccord Genuity | Susan Anderson | Buy | Initiates | $5.00 |
| Oct 9, 2024 | Telsey Advisory Group | Dana Telsey | Outperform | Maintains | $6.00 |
| Sep 4, 2024 | DA Davidson | Linda Bolton Weiser | Buy | Maintains | $7.25 |
Waldencast plc (WALD) Competitors
The following stocks are similar to Waldencast based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Waldencast plc (WALD) Financial Data
Waldencast plc has a market capitalization of $296.54M with a P/E ratio of -6.0x. The company generates $274.56M in trailing twelve-month revenue with a -73.5% profit margin.
Revenue growth is +0.5% quarter-over-quarter, while maintaining an operating margin of -25.4% and return on equity of -33.8%.
Valuation Metrics
Market Cap
$296.54M
Enterprise Value
$508.67M
P/E Ratio
-6.0x
PEG Ratio
0.0x
Price/Sales
1.1x
Growth & Margins
Revenue Growth (YoY)
+0.5%
Gross Margin
N/A
Operating Margin
-25.4%
Net Margin
-73.5%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+3.4%
Current Ratio
1.5x
Debt/Equity
35.2x
ROE
-33.8%
ROA
-4.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Waldencast plc (WALD) Business Model
About Waldencast plc
What They Do
Invests in beauty and wellness businesses.
Business Model
Waldencast plc builds a portfolio of high-growth companies in the beauty and wellness sectors by investing in emerging brands and leveraging its strategic expertise, industry relationships, and financial resources. The company generates revenue by nurturing these brands and facilitating their growth through collaboration with entrepreneurs and the integration of sustainable practices.
Additional Information
Waldencast focuses on sustainability and consumer-centric strategies, responding to trends in conscious consumption and personal well-being. Its operational model emphasizes scaling businesses efficiently using innovative technology and insights from industry experts, making it a key player in promoting new brands in dynamic market segments.
Company Information
Sector
Consumer Defensive
Industry
Household & Personal Products
Employees
335
CEO
Mr. Michel Brousset
Country
United States
IPO Year
2021
Website
www.waldencast.comWaldencast plc (WALD) Latest News & Analysis
Latest News
Quick Summary
Waldencast plc (NASDAQ: WALD) has sold its rights to the "Obagi" trademark in Japan to Rohto Pharmaceutical for $82.5 million.
Why It Matters
Waldencast's sale of Obagi's Japan rights for $82.5 million enhances liquidity, signals strategic refocus, and may influence future growth and market positioning.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Obagi® saypha® ChIQ™ data has been recognized as a top 10 cosmetic oral abstract presentation, indicating significant attention in the cosmetic industry.
Why It Matters
The recognition of Obagi® saypha® ChIQ™ data as a top presentation highlights its potential impact, possibly increasing investor interest and confidence in the company's growth and market position.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
First Half Fiscal 2025 and Q3 2025 financial results will be reported on November 24, 2025.
Why It Matters
The scheduled financial results announcement can impact stock prices, influencing investor sentiment based on performance expectations and market reactions.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
A new scalp serum has been clinically proven to promote fuller and denser-looking hair, potentially indicating growth in the hair care market.
Why It Matters
The launch of a clinically proven scalp serum indicates potential growth in the hair care market, attracting consumer interest and possibly boosting sales for the company involved.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Obagi Medical plans a U.S. launch in 2026, aiming to establish itself as a top dermatological brand and potentially double its addressable market.
Why It Matters
Obagi Medical's U.S. launch in 2026 could significantly expand its market presence, enhancing growth potential and profitability, which may positively impact stock valuation and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Waldencast Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
3 months ago
Quick Summary
Waldencast plc (WALD) will announce its Q2 earnings results on Monday, August 18, after market close.
Why It Matters
Earnings results can significantly impact stock prices, affecting investor sentiment and potential returns. Anticipation or disappointment can lead to volatility in Waldencast plc shares.
Source: Benzinga
Market Sentiment:
Neutral
Frequently Asked Questions About WALD Stock
What is Waldencast plc's (WALD) stock forecast for 2026?
Based on our analysis of 8 Wall Street analysts, Waldencast plc (WALD) has a median price target of $3.50. The highest price target is $4.00 and the lowest is $2.00.
Is WALD stock a good investment in 2026?
According to current analyst ratings, WALD has 3 Buy ratings, 3 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.33. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for WALD stock?
Wall Street analysts predict WALD stock could reach $3.50 in the next 12 months. This represents a 50.2% increase from the current price of $2.33. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Waldencast plc's business model?
Waldencast plc builds a portfolio of high-growth companies in the beauty and wellness sectors by investing in emerging brands and leveraging its strategic expertise, industry relationships, and financial resources. The company generates revenue by nurturing these brands and facilitating their growth through collaboration with entrepreneurs and the integration of sustainable practices.
What is the highest forecasted price for WALD Waldencast plc?
The highest price target for WALD is $4.00 from Susan Anderson at Canaccord Genuity, which represents a 71.7% increase from the current price of $2.33.
What is the lowest forecasted price for WALD Waldencast plc?
The lowest price target for WALD is $2.00 from at , which represents a -14.2% decrease from the current price of $2.33.
What is the overall WALD consensus from analysts for Waldencast plc?
The overall analyst consensus for WALD is neutral. Out of 8 Wall Street analysts, 3 rate it as Buy, 3 as Hold, and 0 as Sell, with a median price target of $3.50.
How accurate are WALD stock price projections?
Stock price projections, including those for Waldencast plc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: December 7, 2025 4:45 AM UTC